Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to ...

When it comes to ultralight backpacking, every gram counts. That’s why I was eager to test the Gossamer Gear The One – a single-skin trekking pole tent that promises big space with minimal weight.

That's where Gossamer's new range of ultra-light packs aims to help - appropriately named as the Type 2 collection. The four new backcountry packs combine a minimalist design with multiple ...

There’s a very specific thrill in swapping out your clunky old rucksack for a sleek, streamlined fastpack that seems to disappear once you put it on, and that’s exactly what Gossamer Gear ...

Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price cut by The Goldman Sachs Group from $8.00 to $7.00 in a research report sent to investors on Thursday,Benzinga reports.They ...

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...